Koki Kato   Tomohiro Mizuno   Takenao Koseki   Yoshimasa Ito   Kazuo Takahashi   Naotake Tsuboi   Shigeki Yamada   
Frontiers in Pharmacology 13 803706-803706 2022年3月 [査読有り]
Information on immune checkpoint inhibitor-induced vasculitides is limited, and predictors for this condition have not been identified. Therefore, we have examined the frequency of immune checkpoint inhibitor-induced vasculitides by analyzing the ...
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 115 218-223 2022年2月 [査読有り]
OBJECTIVES: Favipiravir is an antiviral that is being evaluated for the treatment of COVID-19. Use of favipiravir is associated with elevation of serum uric acid levels. Risk factors for the occurrence of hyperuricemia are unclear. METHODS: Specim...
Polypharmacy in older adults causes problems such as increased adverse drug reactions, overdose or duplication, and poor medication adherence. We have established a "medication review team" organized by pharmacists. This prospective and retrospect...
Anna Ogiso   Tomohiro Mizuno   Kaori Ito   Fumihiro Mizokami   Akihiro Tomita   Shigeki Yamada   
PloS one 17(6) e0269362 2022年
BACKGROUND: The number of patients aged 80 years or older with diffuse large B-cell lymphoma (DLBCL) is increasing, and the incidence rate of the disease in this population group reaches up to 20%. The risk of infection is higher in older patients...
Acute lung injury (ALI) occurs in patients with severe sepsis and has a mortality rate of 40%-60%. Severe sepsis promotes the release of histones from dying cells, which can induce platelet aggregation, activate coagulation and cause endothelial c...